Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ele Ferrannini

Showing results (171-180 of 408) with videos related to

Pageof 41
Sort By:
Journal of Diabetes and Its Complications|January 2, 2013
Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitusVivian A Fonseca, Ele Ferrannini, John P Wilding, et al.
Diabetes Care|October 27, 2006
Polymorphism of the 3'-untranslated region of the leptin receptor gene, but not the adiponectin SNP45 polymorphism, predicts type 2 diabetes: a population-based studyMonica Nannipieri, Rosalinda Posadas, Alessandra Bonotti, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2009
Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonistsAlessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Diabetes|October 27, 2011
Influence of hyperinsulinemia and insulin resistance on in vivo β-cell function: their role in human β-cell dysfunctionAndrea Mari, Andrea Tura, Andrea Natali, et al.
Diabetes|December 12, 2002
Prolonged in vitro exposure to autoantibodies against CD38 impairs the function and survival of human pancreatic isletsPiero Marchetti, Alessandro Antonelli, Roberto Lupi, et al.
Metabolism: Clinical and Experimental|September 28, 2011
Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic modelsAndrea Tura, Giovanni Pacini, Alexandra Kautzky-Willer, et al.
The Journal of Clinical Endocrinology and Metabolism|February 16, 2023
Empagliflozin and Renal Sodium-Hydrogen Exchange in Healthy SubjectsEdoardo Biancalana, Chiara Rossi, Francesco Raggi, et al.
Autoimmunity Reviews|August 31, 2014
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγAlessandro Antonelli, Silvia Martina Ferrari, Alda Corrado, et al.
Trends in Endocrinology and Metabolism: TEM|May 1, 2022
SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver diseaseJun Sung Moon, Jun Hwa Hong, Yong Jin Jung, et al.
Plos One|August 29, 2017
Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes riskKirstine J Belongie, Ele Ferrannini, Kjell Johnson, et al.
Pageof 41

Showing results (171-180 of 408) with videos related to

Sort By:
Pageof 41
Journal of Diabetes and Its Complications|January 2, 2013
Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitusVivian A Fonseca, Ele Ferrannini, John P Wilding, et al.
Diabetes Care|October 27, 2006
Polymorphism of the 3'-untranslated region of the leptin receptor gene, but not the adiponectin SNP45 polymorphism, predicts type 2 diabetes: a population-based studyMonica Nannipieri, Rosalinda Posadas, Alessandra Bonotti, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2009
Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonistsAlessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Diabetes|October 27, 2011
Influence of hyperinsulinemia and insulin resistance on in vivo β-cell function: their role in human β-cell dysfunctionAndrea Mari, Andrea Tura, Andrea Natali, et al.
Diabetes|December 12, 2002
Prolonged in vitro exposure to autoantibodies against CD38 impairs the function and survival of human pancreatic isletsPiero Marchetti, Alessandro Antonelli, Roberto Lupi, et al.
Metabolism: Clinical and Experimental|September 28, 2011
Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic modelsAndrea Tura, Giovanni Pacini, Alexandra Kautzky-Willer, et al.
The Journal of Clinical Endocrinology and Metabolism|February 16, 2023
Empagliflozin and Renal Sodium-Hydrogen Exchange in Healthy SubjectsEdoardo Biancalana, Chiara Rossi, Francesco Raggi, et al.
Autoimmunity Reviews|August 31, 2014
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγAlessandro Antonelli, Silvia Martina Ferrari, Alda Corrado, et al.
Trends in Endocrinology and Metabolism: TEM|May 1, 2022
SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver diseaseJun Sung Moon, Jun Hwa Hong, Yong Jin Jung, et al.
Plos One|August 29, 2017
Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes riskKirstine J Belongie, Ele Ferrannini, Kjell Johnson, et al.
Pageof 41